BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/16/2022 11:59:52 AM | Browse: 895 | Download: 2094
Publication Name World Journal of Gastroenterology
Manuscript ID 77278
Country Canada
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue
Manuscript Source Unsolicited Manuscript
All Author List Alnoor Ramji, Karen Doucette, Curtis Cooper, Gerald Yosel Minuk, Mang Ma, Alexander Wong, David Wong, Edward Tam, Brian Conway, David Truong, Philip Wong, Lisa Barrett, Hin Hin Ko, Sarah Haylock-Jacobs, Nishi Patel, Gilaad G Kaplan, Scott Fung and Carla S Coffin
ORCID
Author(s) ORCID Number
Alnoor Ramji http://orcid.org/0000-0003-4059-8767
Karen Doucette http://orcid.org/0000-0002-1660-9166
Gerald Yosel Minuk http://orcid.org/0000-0002-2687-940X
Mang Ma http://orcid.org/0000-0003-2587-1788
Alexander Wong http://orcid.org/0000-0002-5984-3083
David Wong http://orcid.org/0000-0002-1145-1611
Edward Tam http://orcid.org/0000-0002-8306-3968
Brian Conway http://orcid.org/0000-0001-6821-7829
David Truong http://orcid.org/0000-0002-3190-784X
Philip Wong http://orcid.org/0000-0002-3446-4116
Hin Hin Ko http://orcid.org/0000-0002-2740-2486
Gilaad G Kaplan http://orcid.org/0000-0003-2719-0556
Scott Fung http://orcid.org/0000-0003-0501-8800
Carla S Coffin http://orcid.org/0000-0002-1472-0901
Funding Agency and Grant Number
Corresponding Author Alnoor Ramji, MD, Associate Professor, Department of Medicine, University of British Columbia, 2775 Laurel Str., Gordon and Leslie Diamond Health Care, Vancouver v6t 1z3, Canada. aramji@mail.ubc.ca
Key Words Nucleos(t)ide analog therapy; Functional cure; Hepatitis B virus surface antigen loss; Fibrosis regression; Liver stiffness measurement; Transient elastography
Core Tip In summary in this real-world diverse cohort study of chronic hepatitis B patients in Canada, long-term nucleo(s)ide analog (either 1st or 2nd generation) therapy suppresses hepatitis B virus DNA and improves hepatic inflammation and liver fibrosis, as determined by non-invasive testing (i.e., transient elastography). In patients treated for up to 5 years, none achieved hepatitis B surface antigen loss (functional cure), highlighting the need for improved therapeutic strategies to reduce the life-long burden of antiviral therapy.
Publish Date 2022-08-16 11:59
Citation Ramji A, Doucette K, Cooper C, Minuk GY, Ma M, Wong A, Wong D, Tam E, Conway B, Truong D, Wong P, Barrett L, Ko HH, Haylock-Jacobs S, Patel N, Kaplan GG, Fung S, Coffin CS. Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue. World J Gastroenterol 2022; 28(31): 4390-4398
URL https://www.wjgnet.com/1007-9327/full/v28/i31/4390.htm
DOI https://dx.doi.org/10.3748/wjg.v28.i31.4390
Full Article (PDF) WJG-28-4390.pdf
Full Article (Word) WJG-28-4390.docx